cilastatin has been researched along with Colonic Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Abe, Y; Aoki, N; Arita, M; Goto, S; Hayashi, M; Hokari, S; Hosojima, M; Ichikawa, K; Kabasawa, H; Kikuchi, T; Kondo, R; Koya, T; Kuwahara, S; Nozaki, K; Ohshima, Y; Ohtsubo, A; Saito, A; Sato, M; Shoji, S; Suzuki, R; Takahashi, M; Watanabe, S | 1 |
Cho, HJ; Kim, BY; Kim, JT; Kim, JW; Kim, TW; Lee, CH; Lee, HG; Lee, SJ; Lee, Y; Lim, JS; Park, SY; Yeom, YI | 1 |
2 other study(ies) available for cilastatin and Colonic Neoplasms
Article | Year |
---|---|
Combination therapy of cisplatin with cilastatin enables an increased dose of cisplatin, enhancing its antitumor effect by suppression of nephrotoxicity.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Proliferation; Cilastatin; Cisplatin; Colonic Neoplasms; Female; Glomerular Filtration Rate; Humans; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Inbred NOD; Mice, SCID; Renal Insufficiency; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2021 |
Dehydropeptidase 1 promotes metastasis through regulation of E-cadherin expression in colon cancer.
Topics: Animals; Antigens, CD; Cadherins; Cell Adhesion; Cell Line, Tumor; Cilastatin; Colonic Neoplasms; Dipeptidases; Epithelial-Mesenchymal Transition; Female; GPI-Linked Proteins; HCT116 Cells; HT29 Cells; Humans; Leukotriene D4; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; RNA Interference; RNA, Messenger; RNA, Small Interfering; Transforming Growth Factor beta; Transplantation, Heterologous | 2016 |